SUZHOUBEARING
430418
WANDA BEARING
920002
Shandong Rike Chemical
300214
4
Jiangsu LiXing General Steel Ball
300421
5
Jiangsu Boiln Plastics
301003
US Stock MarketDetailed Quotes
GTBP GT Biopharma
- 2.4600
- +0.4300+21.18%
Close Feb 25 16:00 ET
- 2.2600
- -0.2000-8.13%
Post 19:59 ET
5.50MMarket Cap-0.35P/E (TTM)
3.1200High2.0200Low26.70MVolume2.4600Open2.0300Pre Close75.93MTurnover1663.08%Turnover RatioLossP/E (Static)2.23MShares10.659952wk High-3.29P/B3.95MFloat Cap1.720052wk Low--Dividend TTM1.61MShs Float591.9900Historical High--Div YieldTTM54.19%Amplitude1.7200Historical Low2.8440Avg Price1Lot Size
GT Biopharma Key Stats
EPS
According to the latest financial report of GT Biopharma, the latest earnings per share (TTM) for the company is -1.53. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about GT Biopharma's free cash flow? The latest report shows it as -2.74M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of GT Biopharma shows that the company's current ratio is 1.45, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of GT Biopharma, the quick ratio is 1.38, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of GT Biopharma? The latest ROE figure is -89.73%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of GT Biopharma, the total asset return on investment (ROA) is -42.57%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check GT Biopharma's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of GT Biopharma, the net profit margin is 134.30K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025